 |
Barcelona, November 5, 2009
Introduction|
Program|
Who should attend|
Chairman|
The themes of our previous meetings were:|
Media Sponsor|
|
|
Introduction
Competition is on the rise in the pharmaceutical industry. Growth forecasts are positive worldwide, but
Western markets profits are threatened by the difficulties of implementing innovation and the expansion of
generic drugs. The industry is reacting with mergers, acquisitions and other formulas to optimize R&D, improve operations and boost sales by looking for products with longer, more profitable life cycles.
Program
| 8:30 - 9:00 | Registration and distribution of conference materials
| | 9:00 - 9:30 | Opening Session
- Jesús Acebillo, President, Farmaindustria
- Prof. Pedro Nueno, IESE
| | 9:30 - 10:00 | Coffee Break
| | 10:00 - 12:00 | Business Models
The pharmaceutical model is costly and presents difficulties for the development of new products. Profitable and growth strategies for the future center on adopting new approaches to innovation and adjusting operations. Health-related consumer biotech markets are growing and offer opportunities.
- Dr. Bernard Courtieu, Chief Executive Officer, IntegraGen
- Belén Garijo, Vice President Europe and Canada, Sanofi-Aventis
- Eduardo Sanchiz, Chief Executive for Corporate Development & Finance, Almirall
- Antoni Villaró, President and CEO, Otsuka Pharmaceutical Europe
Moderator: Prof. Pedro Nueno, IESE
| | 12:00 - 12:15 | Break
| | 12:15 - 13:45 | Selling on the Global Market
The global market is growing, although differently, depending on the geographic areas. This is a time of excellence in sales performance and the need to find the right role for marketing.
- Didier Barret, President, Europe, Middle East and Africa (EMEA), Mylan
- Adrian Grecu, Commercial Director China, Russia and India, Abbott Laboratories (Singapore)
- Leandro Sigman, Managing Director, Chemo Group
Moderator: Prof. Pedro Nueno, IESE
| | 13:45- 14:15 | Challenges and Future Perspectives for the Pharmaceutical Sector
The European pharmaceutical sector faces significant structural challenges. Future market trends make it necessary to pursue strategic advantages and increased asset flexibility.
- Reinhard Vocke, Co-Owner, Management Engineers GmbH + Co. KG
Moderator: Prof. Pedro Nueno, IESE
| | 14:15 - 15:45 | Lunch
| | 15:45- 17:30 | The Industry in Spain
The industry has responded to the demands of the Spanish market. However, growth and competitiveness depend upon a stable framework that encourages commitment to medium-term investments.
- Humberto Arnés, Managing Director, Farmaindustria
- Javier Ellena, Chairman, Lilly Spain
- Antoni Esteve, Chairman, Esteve
Moderator: Prof. Antonio Monge, General Director, Applied Pharmabiology Research Center (CIFA), Universidad de Navarra
| | 17:30 - 18:15 | Conclusions and Official Closing
Humberto Arnés, Managing Director, Farmaindustria
Prof. Pedro Nueno, IESE
Marina Geli, Minister of Health, Government of Catalonia |
| | | | | | | | | | | | | | | | | | | | | | | | | |
Who should attend
The conference is aimed at presidents, managing directors and senior executives of pharmaceutical companies, as well as healthcare professionals in general. It will also attract senior managers of public healthcare institutions.
Chairman
|  | Prof. Pedro Nueno
Department of Entrepreneurship, IESE
Bertrán Foundation Chair of Entrepreneurship
Doctor of Business Administration, Harvard University |
|
The themes of our previous meetings were:
(to view contents please click on the title)
Media Sponsor
|
|
|
|
|
|
In accordance with the wording of the Organic Act 15/99, IESE, Universidad de Navarra (hereinafter IESE), informs that the Personally Identifiable Information (Personal Information) used in this communication, is included in a computerized file of which IESE is ultimately responsible for. If you wish to exercise your rights of access, modification, cancellation and/or opposition, you can send a letter to InfoDat, Av. Pearson 21, 08034, Barcelona or an electronic mail to InfoDat@iese.edu
|
|
|
|
|
|
|
Barcelona (+34) 93 253 42 00 |
|
Madrid (+34) 91 211 30 00 |
|
|
|
|
|
|
|
